USPTO serial 97448256
IMMUNOVATION
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 25, 2024
- Examiner
- LEE, YATSYE ISADORA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with IMMUNOVATION?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Gunnar Bjorn Gundersen
Gunnar Bjorn Gundersen Gundersen & Gundersen LLP5000 Birch St., West Tower, Suite 3000Newport Beach, CA 92660United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Promoting public awareness of immunological issues, drug development, and women's health; promoting the interests of women by means of public advocacy | ACTIVE | Aug 9, 2019 |
| 041 | Educational services, namely, providing pre-recorded performances in the nature of non-downloadable audio and video clips in the field of immunological issues, drug development, and women's health; Providing a web site featuring pre-recorded performances in the nature of non-downloadable audio and video clips in the field of immunological issues, drug development, and women's health | ACTIVE | May 23, 2022 |
| 042 | Providing scientific research information in the field of immunological issues, drug development, and women's health; providing a website featuring scientific research information in the field of immunological issues, drug development, and women's health | ACTIVE | Aug 9, 2019 |
| 044 | Pharmaceutical consulting services in the fields of immunology, drug development, and women's health; Providing a website featuring medical and pharmaceutical information on immunology, drug development, and women's health; Providing medical and pharmaceutical information about immunology, drug development, and women's health; Health counseling services in the field of services in the field of immunology, drug development, and health and wellness for women | ACTIVE | Aug 9, 2019 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ImmunoVation, LLC
- Other trademarks owned by ImmunoVation, LLC
- Other trademarks owned by ImmunoVation, LLC
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named IMMUNOVATION
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 9, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 9, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 9, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 25, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 25, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 20, 2024 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| May 20, 2024 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Apr 16, 2024 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Apr 16, 2024 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Mar 27, 2024 | IUAF | USE AMENDMENT FILED | — |
| Mar 27, 2024 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Mar 5, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 9, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 9, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 20, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 6, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 29, 2023 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Nov 29, 2023 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Nov 29, 2023 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Nov 27, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 27, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 27, 2023 | ALIE | ASSIGNED TO LIE | — |
| Jun 21, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 23, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 23, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 23, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 23, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 22, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 11, 2022 | NWAP | NEW APPLICATION ENTERED | — |